CAP1 and Sepsis: As a ligand, RETN engages receptors such as TLR4 and CAP1 and activates the NF-κB signaling pathway, which promotes release of large amounts of proinflammatory cytokines and drives the systemic inflammatory response in early sepsis (45, 46).